Emerging Therapies

Hot Topics in RA: Debates and Discussion from Rome

Hot Topics in RA: Debates and Discussion from Rome

Methotrexate (MTX) has served as the cornerstone of rheumatoid arthritis (…

Expiration Date: 9/10/2019

Max Credits: 0

View Activity

On the Scenes at EULAR: Updates on Current and Emerging Therapies

On the Scenes at EULAR: Updates on Current and Emerging Therapies

Clinicians have several classes of highly effective biologic and conventio…

Expiration Date: 8/4/2016

Max Credits: 0

View Activity

Updates from Rome: Translating Advances in Immunology into the Management of Rheumatic Diseases

Updates from Rome: Translating Advances in Immunology into the Management of Rheumatic Diseases

The treatment armamentarium for rheumatoid arthritis (RA) has seen massive…

Expiration Date: 8/4/2016

Max Credits: 0

View Activity

RA Forum Pre-study: Applying Immunologic Management Approaches in Rheumatoid Arthritis

RA Forum Pre-study: Applying Immunologic Management Approaches in Rheumatoid Arthritis

The recent advent of biologic disease modifying anti-rheumatic drugs (DMAR…

Expiration Date: 4/23/2016

Max Credits: 0

View Activity

Biomarkers (RF, CCP, and 14-3-3η)

Biomarkers (RF, CCP, and 14-3-3η)

Dr. Maksymowych will discuss how to understand the role of a novel mediato…

Expiration Date: 7/20/2015

Max Credits: 0

View Activity

IL-17: A Target for Therapy in RA

IL-17: A Target for Therapy in RA

Interleukin 17 (IL-17), a cytokine mainly produced by T cells, was definit…

Expiration Date: 6/30/2015

Max Credits: 0

View Activity

Kinase Inhibitors: Current and Potential

Kinase Inhibitors: Current and Potential

Dr. Markenson discusses the role of protein kinases in signal transduction…

Expiration Date: 8/14/2015

Max Credits: 0

View Activity

Rheumatoid Arthritis: Treatment Advances and Individualized Therapy

Rheumatoid Arthritis: Treatment Advances and Individualized Therapy

The management of rheumatoid arthritis is rapidly evolving, with the appro…

Expiration Date: 4/15/2015

Max Credits: 0

View Activity